Can a digital rehab program help colon cancer patients recover at home?
NCT ID NCT06593678
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 3 times
Summary
This study tests whether a home-based telerehabilitation program can improve functional capacity and quality of life for patients recovering from colorectal cancer surgery. Fifty-four participants will either follow the digital program or receive a standard booklet. The goal is to see if remote exercise and support can aid recovery without needing frequent hospital visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Telerehabilitation program (asynchronous digital platform with exercise videos)
- What this could lead to
- If it works, this could offer a convenient, home-based way to help colorectal cancer patients recover faster and feel better after surgery.
- What could go wrong
- This is a small, early-stage trial with only 54 participants, so results may not apply to everyone. The program depends on patient motivation and access to technology.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Royo Villanova
Zaragoza, Zaragoza, 50015, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?